Skip to main contentrtttttt Skip to main content
Integrative Psychiatry

Fiber: The Forgotten Macro

At the Integrative Psychiatry Institute, we talk a lot about dietary and microbiome interventions for mental health support. Optimized nutritional requirements are complex and can be unique from person to person, depending on genetics, development, and lifestyle; it is common to hear individuals advocating for a specific botanical, multivitamin, or probiotic that worked for them. Yet there is one macronutrient, often overlooked, that stands out in promoting gut-brain health: fiber. Fiber is a crucial component of a healthy diet, offering numerous physiological and cognitive benefits. It can also be a more efficient and affordable alternative to supplements!

Understanding Fiber

Fiber is a type of carbohydrate found in plant-based foods that our bodies cannot digest alone. Instead, it passes through the digestive system relatively intact, requiring fermentation by gut microbes to break down. Soluble fiber dissolves in water to produce a gel-like substance that slows digestion; meanwhile, insoluble fiber attracts water as it moves through the digestive tract, adding bulk to stool. 

While recommended intake of fiber varies depending on biological and environmental contexts, guidelines suggest aiming for around 30 grams per day for adults. However, many individuals fall short of these recommendations. Increasing fiber consumption through food choices can have a profound impact, helping to support digestive, metabolic, immune, and cardiovascular health. 

The Gut-Brain Axis

Fiber nourishes the gut microbiome and influences the gut-brain axis. You see, fiber serves as a prebiotic, acting as food for gut bacteria. This food gets broken down and absorbed into the circulation, traveling throughout the body, including to the brain where these metabolites impact neural function. Fiber may be fermented into short-chain fatty acids like acetate, butyrate, and propionate, exerting neuroprotective effects. Studies suggest that diets rich in fiber are associated with a lower risk of depression and anxiety, as well as improved stress management and cognitive function.

The intricate network between the gut and the brain, known as the gut-brain axis, highlights the relationship between gut health and mental wellbeing. Immune and nervous systems communicate bidirectionally, meaning from body to the brain and the brain to the body. The composition of the gut microbiome influences brain function and behavior through various pathways, including metabolite, hormone, and neurotransmitter production. Eating different types of plant-based foods can promote the expansion of microbial diversity; having lots of different types of gut microbes leads to a balance of metabolic byproducts and is associated with enhanced mood and cognitive function. 

Putting Fiber into Practice

Nurturing a healthy microbiome through fiber-rich diets may support a holistic approach to mental health. Consider buying less processed foods. The packaging and marketing of shelf-stable items can be misleading, boasting false health benefits; it may be helpful to read nutrition labels before adding them to the cart. 

Swapping out white bread for whole-grain and incorporating fresh fruits, vegetables, beans, and nuts are just a couple of ways to introduce more fiber. 

Consuming high-fiber, plant-based foods will also simultaneously provide:

  1. Satisfying meals that regulate blood glucose levels
  2. Uptake of vitamins and minerals
  3. Exposure to additional helpful bacteria living on and in living plants (like produce)

In clinical practice, it may be enough to simply provide psychoeducation and encourage individuals to gradually increase their fiber intake, experimenting with diverse sources of fiber to amplify vitality and resilience. 

Sara Reed, MS, LMFT

Sara Reed is a Licensed Marriage and Family Therapist and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. As a mental health futurist and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. Sara’s prior research work includes participation as a study therapist in psychedelic therapy research at Yale University and the University of Connecticut’s Health Center. Sara was the first Black therapist to provide MDMA-assisted psychotherapy in a clinical trial and continues to engage in ongoing advocacy work around health equity in psychedelic medicine.

https://psychiatryinstitute.com/wp-content/uploads/2019/11/Jeffrey-Guss.png

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psychedelic-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psychedelic-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psychedelic-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with Psychedelic-Assisted Psychotherapy. 

Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He has published (with Elizabeth Nielson, PhD) a paper on “the influence of therapists’ first had experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training” in The Journal of Psychedelic Studies, August, 2018. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Supervisor in NYU’s Fellowship in Addiction Psychiatry. 

Dr. Guss maintains a private practice in New York City.

Will Van Derveer, MD

Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.

Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.


Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.

In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.

Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.

Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.

He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.

Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.